Optimus Pharma launched a new Anti-Parkinson’s Drug in India

Hyderabad (Telangana) [India], April 26: Optimus Pharma has announced today that it has received DCGI approval for its Anti-Parkinson’s drug Safinamide. Safinamide is indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing “off” episodes.

The burdens of Parkinson’s Disease (PD) are undeniably serious and increasing while various unmet needs remain, especially the absence of disease-modifying therapies, especially in Indian Market. Optimus believes Safinamide will give an additional option to healthcare professionals in the treatment of Parkinson’s and improve the quality of life of millions who are affected by Parkinson’s disease. A homegrown generic version of Safinamide developed by Optimus will assist in delivering robust treatment for Parkinson’s diseases in India with very high affordability and accessibility.

About Parkinson’s Disease

Parkinson’s disease (PD) is one of the most common neurologic disorders, affecting approximately 1% of individuals older than 60 years and causing progressive disability that can be slowed but not halted, by treatment. Parkinson’s disease is a movement disorder that causes involuntary movements and rigidity, as well as abnormal walking and posture. It is caused by an imbalance between two chemicals that transmit signals from the brain, dopamine, and acetylcholine.

Disclaimer:

Statements in this “Document” describing the Company’s objectives, projections, estimates, expectations, plans or predictions, or industry conditions or events may be “forward-looking statements” within the meaning of applicable securities laws and regulations. Actual results, performance, or achievements could differ materially from those expressed or implied. The Company undertakes no obligation to update or revise forward-looking statements to reflect developments or circumstances that arise or to reflect the occurrence of unanticipated developments/circumstances after the date hereof.

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Marching Towards Colorectal Cancer Awareness: Prevention, Detection, and Treatment

New Delhi (India), March 31: March is observed as Colorectal Cancer Awareness Month globally to raise awareness about the importance of early screening and prevention of colorectal cancer. Colorectal cancer is the third most common cancer and a leading cause of cancer deaths worldwide. However, despite the availability of screening measures, there is a significant […]

Read More
Business

Ultra Media and Entertainment Launches Marathi OTT Platform “Ultra Jhakaas”

Mumbai (Maharashtra) [India], March 31: Ultra Media and Entertainment, a leading provider of entertainment content in India since 1982, has launched its new Marathi OTT platform “Ultra Jhakaas” that promises an unmatched content and viewing experience for its users.The new platform offers a vast library of movies, TV shows, web series and other premium content […]

Read More
Business

Anuvrat Yatra: Param Pujya Acharya Shri Mahashraman will Reach Surat on 21st April

2100 Surat devotees attended the ceremony of “Daitva Swikaran” in Ahmedabad. Over 1111 Varshitap Parna will be held on Akshaya Tritya in Presence of Acharya Shri Mahashraman in Surat. Surat (Gujarat) [India], March 31: On the occasion of Akshaya Tritiya Mahotsav, over 1111 Varshitap Parna will be held in Surat on April 23 in the […]

Read More